Canton Strategic Holdings, Inc. (CNTN)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $2.02
- As of
Kresmion compiles this page from CNTN's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Canton Strategic Holdings, Inc. (CNTN): 2 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-14.
See the full CNTN dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CNTN on one page. Preview it with sample data, then open it live with a free account.
Preview the CNTN dossierActive signals for CNTN
- mediumNEW_POSITION
CITADEL ADVISORS LLC new position in CNTN
- highINSTITUTIONAL_EXIT
RENAISSANCE TECHNOLOGIES LLC cut 66% of CNTN (2026Q2)
- mediumcorporate_crypto_treasury
Canton Strategic Holdings, Inc. 8-K references ETH treasury activity · filed 2026-08-14
- mediumEARNINGS_MISS
Q1-2023: Missed consensus by 105.0% - EPS $-86.25 vs $-42.075 estimate
- mediumEARNINGS_MISS
Q3-2023: Missed consensus by 79.7% - EPS $-41.25 vs $-22.95 estimate
FREE, NO ACCOUNT
Every signal on CNTN, as it fires
You are seeing 5 of 9 signals recorded on CNTN since 2026-05-29.
The five above landed across 3 days. The other 4 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in CNTN (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 432705309 · 2026Q2 | $535K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 432705309 · 2026Q2 | $46K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, CNTN
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
CNTN against its peers
CNTN's return on equity of -9.0% ranks in the 88th percentile of 20 Biotechnology sub-industry peers, fiscal periods ending between 2025-09-30 and 2025-12-31.
| Metric | CNTN | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | n/a | 7.7M | n/a | 11 |
| Operating margin | n/a | -326.6% | n/a | 9 |
| Net margin | n/a | -229.6% | n/a | 9 |
| Return on equity | -9.0% | -57.8% | 88 | 20 |
| 1 year | -30.8% | -45.1% | 61 | 13 |
Peers (21): NKTX, TARA, MSLE, MOLN, MDWD, CMPX, ORGO, AVXL, ADAG, PEPG, PMVP, NBP, MENS, CHRS, ANTX, KRRO, CBUS, ALXO, ENGN, DTIL, VYGR. Left out: OTLK (no annual filing), RNA (no annual filing), TLSA (period gap), BETRF (period gap). Fiscal periods ending between 2025-09-30 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (CNTN: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow CNTN on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to CNTN for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.